See: Mooreast submits preliminary prospectus amid year end surge in IPOs
The appraised value of the IPO portfolio is approximately ¥80.57 billion ($952.9 million). The agreed purchase value is estimated at ¥71.07 billion ($840.5 million).
The annualised distribution per unit yield in 2021 is forecast to be around 6.3%, rising to 6.5% in 2022. The IPO price is estimated at 80 cents, and net asset value is likely to be 81 cents.
For more stories about where the money flows, click here for our Capital section
See also: Chery is said to near Hong Kong listing as billion-dollar IPOs return to city
The cornerstone investors are Bangkok Life Assurance Public Co, Credit Suisse, various units in DBS Bank, Nomura Securities, DWS Investments Australia, Kuan Meng Investments which belongs to Philip Ng, Metro ARC Investments, a unit of Metro Holdings and Hazelview Securities.
